arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

BioCryst Pharmaceuticals, Inc.

BCRX Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$8.41
▼ -0.7% Today
as of Jun 7, 07:10 ET
Last 30 days -5.08% Apr 28 → Jun 05
$8.14 $8.53 $8.93 $9.32 $9.71 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$8.50
High
$8.60
Low
$8.34
Volume
$3M
Avg Vol
$4M
Mkt Cap
$2.3B
P/E (TTM)
Beta
52w High
$11.23
52w Low
$6.00
Div Yield
Shares Out
$254M

Overview

52-week range
$6.00
$11
46% of range
Avg surprise (last 2)
-25.0%
Avg reaction (last 2)
+10.7%
50% positive
Latest IV / EM
107%
EM ±14.9% · $8 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.40$-0.29$-0.17$-0.05$0.06 Actual $-0.40Actual $-0.19Actual $-0.17Actual $-0.06Actual $-0.07Est $-0.07Actual $0.02Actual $0.06Actual $-0.03Est $0.06 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-722M$-538M$-354M$-170M$14M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 6, 2026Mar/2026 $-0.03 $0.06 -150.0% -2.2% earnings
Tue Sep 30, 2025Sep 2025 $0.06 financials
Mon Jun 30, 2025Jun 2025 $0.02 financials
Mon May 5, 2025Mar/2025 $-0.07 +100.0% +23.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.07 financials
Sun Jun 30, 2024Jun 2024 $-0.06 financials
Sun Mar 31, 2024Mar 2024 $-0.17 financials
Sat Sep 30, 2023Sep 2023 $-0.19 financials
Fri Jun 30, 2023Jun 2023 $-0.40 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$5M$2M$3M$5M$3M$2M
Gross profit
Operating income$-702M$30M$30M$21M$8M$9M
Net income$-722M$13M$5M$32,000$-14M$-13M
EPS (diluted)$-2.98$0.06$0.02$-0.07$-0.06

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$172M$90M$84M$88M$105M$105M$97M$78M
Inventory$6M$5M$5M$5M$7M$8M$8M$4M
Total current assets$374M$404M$356M$398M$410M$422M$427M$363M
Total assets$465M$514M$446M$457M$480M$490M$491M$472M
Long-term debt$395M$0$194M$243M$315M$315M$314M$314M
Total liabilities$1.02B$633M$834M$879M$932M$966M$960M
Total equity$-554M$-119M$-388M$-422M$-452M$-476M$-469M$-476M

Implied volatility — last 90 days

102%104%107%109%112% Jun 07 — IV 107% · EM ±14.9%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.